To further demonstrate the inhibitory effects of CAMK4 on liver cancer cells, we constructed CAMK4-overexpressing HepG2 and BEL-7402 cells by plasmid transfection and named control group, NC group, and CAMK4 group, respectively. The gene discussed is CAMK4; the disease is liver cancer.